Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens

Molecular Immunology

Volumn 45, Issue 10, 2008, Pages 2808-2819

  Kuhn, Kristine A ^a   Cozine, Cassy L ^a   Tomooka, Beren ^b,c   Robinson, William H ^b,c   Holers, V Michael ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Arthritis; Autoantibodies; B cells; Citrulline; CR2

Indexed keywords

ANTIGEN; AUTOANTIBODY; CITRULLINE; COLLAGEN TYPE 2; COMPLEMENT COMPONENT C3B RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; GENETIC VARIABILITY; INCIDENCE; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN TARGETING;

ANIMALS; ANTIBODY FORMATION; ANTIGENS; ARTHRITIS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; CITRULLINE; COLLAGEN TYPE II; COMPLEMENT C3; FREUND'S ADJUVANT; IMMUNIZATION; JOINTS; MICE; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D;

BOVINAE; MURINAE; MUS;

EID: 41849112297     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.01.036     Document Type: Article

References (40)

1. Asokan R., Hua J., Young K.A., Gould H.J., Hannan J.P., Kraus D.M., Szakonyi G., Grundy G.J., Chen X.S., Crow M.K., and Holers V.M. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus. J. Immunol. 177 (2006) 383-394
2. Aubry J.P., Pochon S., Gauchat J.F., Nueda-Marin A., Holers V.M., Graber P., Siegfried C., and Bonnefoy J.Y. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J. Immunol. 152 (1994) 5806-5813
3. Brand D.D., Marion T.N., Myers L.K., Rosloniec E.F., Watson W.C., Stuart J.M., and Kang A.H. Autoantibodies to murine type II collagen in collagen-induced arthritis: a comparison of susceptible and nonsusceptible strains. J. Immunol. 157 (1996) 5178-5184
4. Del Nagro C.J., Kolla R.V., and Rickert R.C. A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis. J. Immunol. 175 (2005) 5379-5389
5. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 14863-14868
6. Fearon D.T., and Carter R.H. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13 (1995) 127-149
7. Fingeroth J.D., Weis J.J., Tedder T.F., Strominger J.L., Biro P.A., and Fearon D.T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 4510-4514
8. Fleming S.D., Shea-Donohue T., Guthridge J.M., Kulik L., Waldschmidt T.J., Gipson M.G., Tsokos G.C., and Holers V.M. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J. Immunol. 169 (2002) 2126-2133
9. Grant E.P., Picarella D., Burwell T., Delaney T., Croci A., Avitahl N., Humbles A.A., Gutierrez-Ramos J.C., Briskin M., Gerard C., and Coyle A.J. Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J. Exp. Med. 196 (2002) 1461-1471
10. Hietala M.A., Jonsson I.M., Tarkowski A., Kleinau S., and Pekna M. Complement deficiency ameliorates collagen-induced arthritis in mice. J. Immunol. 169 (2002) 454-459
11. Hsu H.C., Wu Y., Yang P., Wu Q., Job G., Chen J., Wang J., Accavitti-Loper M.A., Grizzle W.E., Carter R.H., and Mountz J.D. Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J. Immunol. 178 (2007) 5357-5365
12. Hueber W., Kidd B.A., Tomooka B.H., Lee B.J., Bruce B., Fries J.F., Sonderstrup G., Monach P., Drijfhout J.W., van Venrooij W.J., Utz P.J., Genovese M.C., and Robinson W.H. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum. 52 (2005) 2645-2655
13. Hummon A.B., Lim S.R., Difilippantonio M.J., and Ried T. Isolation and solubilization of proteins after TRIzol extraction of RNA and DNA from patient material following prolonged storage. Biotechniques 42 (2007) 467-470 472
14. Iida K., Nadler L., and Nussenzweig V. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J. Exp. Med. 158 (1983) 1021-1033
15. Kaya Z., Afanasyeva M., Wang Y., Dohmen K.M., Schlichting J., Tretter T., Fairweather D., Holers V.M., and Rose N.R. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat. Immunol. 2 (2001) 739-745
16. Kuhn K.A., Kulik L., Tomooka B., Braschler K.J., Arend W.P., Robinson W.H., and Holers V.M. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J. Clin. Invest. 116 (2006) 961-973
17. Kurtz C.B., O'Toole E., Christensen S.M., and Weis J.H. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144 (1990) 3581-3591
18. Lyubchenko T., dal Porto J., Cambier J.C., and Holers V.M. Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathway. J. Immunol. 174 (2005) 3264-3272
19. McCluskey J., Farris A.D., Keech C.L., Purcell A.W., Rischmueller M., Kinoshita G., Reynolds P., and Gordon T.P. Determinant spreading: lessons from animal models and human disease. Immunol. Rev. 164 (1998) 209-229
20. Meyer O., Nicaise-Roland P., Santos M.D., Labarre C., Dougados M., Goupille P., Cantagrel A., Sibilia J., and Combe B. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. Arthritis Res. Ther. 8 (2006) R40
21. Molina H., Kinoshita T., Inoue K., Carel J.C., and Holers V.M. A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 145 (1990) 2974-2983
22. Molina H., Holers V.M., Li B., Fung Y., Mariathasan S., Goellner J., Strauss-Schoenberger J., Karr R.W., and Chaplin D.D. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3357-3361
23. Morgan K., Clague R.B., Shaw M.J., Firth S.A., Twose T.M., and Holt P.J. Native type II collagen-induced arthritis in the rat: the effect of complement depletion by cobra venom factor. Arthritis Rheum. 24 (1981) 1356-1362
24. Poe J.C., Hasegawa M., and Tedder T.F. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction. Int. Rev. Immunol. 20 (2001) 739-762
25. Pozdnyakova O., Guttormsen H.K., Lalani F.N., Carroll M.C., and Kasper D.L. Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. J. Immunol. 170 (2003) 84-90
26. Rantapaa-Dahlqvist S., de Jong B.A., Berglin E., Hallmans G., Wadell G., Stenlund H., Sundin U., and van Venrooij W.J. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48 (2003) 2741-2749
27. Reid R.R., Woodcock S., Shimabukuro-Vornhagen A., Austen Jr. W.G., Kobzik L., Zhang M., Hechtman H.B., Moore Jr. F.D., and Carroll M.C. Functional activity of natural antibody is altered in Cr2-deficient mice. J. Immunol. 169 (2002) 5433-5440
28. Robinson W.H., DiGennaro C., Hueber W., Haab B.B., Kamachi M., Dean E.J., Fournel S., Fong D., Genovese M.C., de Vegvar H.E., Skriner K., Hirschberg D.L., Morris R.I., Muller S., Pruijn G.J., van Venrooij W.J., Smolen J.S., Brown P.O., Steinman L., and Utz P.J. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8 (2002) 295-301
29. Solomon S., Kolb C., Mohanty S., Jeisy-Walder E., Preyer R., Schollhorn V., and Illges H. Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35). Eur. J. Immunol. 32 (2002) 644-651
30. Stuart J.M., and Dixon F.J. Serum transfer of collagen-induced arthritis in mice. J. Exp. Med. 158 (1983) 378-392
31. Svensson L., Jirholt J., Holmdahl R., and Jansson L. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin. Exp. Immunol. 111 (1998) 521-526
32. Tedder T.F., Zhou L.J., and Engel P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 15 (1994) 437-442
33. Terato K., Hasty K.A., Reife R.A., Cremer M.A., Kang A.H., and Stuart J.M. Induction of arthritis with monoclonal antibodies to collagen. J. Immunol. 148 (1992) 2103-2108
34. Tolnay M., and Tsokos G.C. Complement receptor 2 in the regulation of the immune response. Clin. Immunol. Immunopathol. 88 (1998) 123-132
35. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5116-5121
36. Vanderlugt C.L., and Miller S.D. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2 (2002) 85-95
37. Wang Y., Kristan J., Hao L., Lenkoski C.S., Shen Y., and Matis L.A. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J. Immunol. 164 (2000) 4340-4347
38. Watson W.C., and Townes A.S. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J. Exp. Med. 162 (1985) 1878-1891
39. Wooley P.H., Luthra H.S., Stuart J.M., and David C.S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154 (1981) 688-700
40. Wu X., Jiang N., Fang Y.F., Xu C., Mao D., Singh J., Fu Y.X., and Molina H. Impaired affinity maturation in Cr2-/- mice is rescued by adjuvants without improvement in germinal center development. J. Immunol. 165 (2000) 3119-3127